VTR
44
4
SBUX
29
-2
ORLY
48
3
VMC
41
2
AN
49
2
THC
52
9
EMR
57
7
KR
50
5
ECL
54
5
SNA
56
3
XYL
29
4
SO
48
6
DGX
28
4
ZTS
38
4
CVX
25
14
AIZ
61
5
ICE
53
5
CTSH
55
3
LH
33
3
AAPL
64
3
VTR
44
4
SBUX
29
-2
ORLY
48
3
VMC
41
2
AN
49
2
THC
52
9
EMR
57
7
KR
50
5
ECL
54
5
SNA
56
3
XYL
29
4
SO
48
6
DGX
28
4
ZTS
38
4
CVX
25
14
AIZ
61
5
ICE
53
5
CTSH
55
3
LH
33
3
AAPL
64
3
Financhill
Back

NuCana PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
17

NCNA
NuCana PLC

Last Price:
$1.20
Seasonality Move:
10.84%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
$0.60
Seasonality Move:
36.97%
Sell
17
NuCana PLC (NCNA) is a Sell

Is NuCana PLC a Buy, Sell or Hold?

  • The current NuCana PLC [NCNA] share price is $1.20. The Score for NCNA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • NCNA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.60. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NCNA Stock Price Chart

What is NuCana PLC's stock price today?

  • The NuCana PLC share price today is $1.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

NCNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 33.88 Sell
Chaikin Money Flow: -25315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.23 - 1.35) Sell
Bollinger Bands (100): (0.81 - 4.61) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.3 Sell
Chaikin Money Flow: 3030174 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.7) Sell
Bollinger Bands (100): (0.69 - 1.09) Sell

NCNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.25 Sell
20-day SMA: 1.27 Sell
50-day SMA: 1.5 Sell
200-day SMA: 3.56 Sell
8-day EMA: 1.25 Sell
20-day EMA: 1.3 Sell
50-day EMA: 1.65 Sell
200-day EMA: 4.27 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.65 Sell
50-day SMA: 0.72 Sell
200-day SMA: 1.04 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.64 Sell
50-day EMA: 0.73 Sell
200-day EMA: 0.93 Sell

NuCana PLC Earnings Growth & NCNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.06 per share, and a decrease next year of $7.72 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.

NuCana PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):